Does facility-level variation in rates of definitive therapy for low-risk prostate cancer among men with limited life expectancy present an opportunity for Value-Based Care redesign? @Putnam_Cole’s discusses this crucial topic at #EAU18 @MichaelEPorter @robert_huckman https://t.co/hdqkWY90LU
Does facility-level variation in rates of definitive therapy for low-risk prostate cancer among men with limited life expectancy present an opportunity for Value-Based Care redesign? @Putnam_Cole’s discusses this crucial topic at #EAU18 @MichaelEPorter @robert_huckman https://t.co/hdqkWY90LU